Page last updated: 2024-12-07
4-methyl-1,2,4-triazoline-3,5-dione
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
4-methyl-1,2,4-triazoline-3,5-dione: structure given in ifrst source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 128854 |
SCHEMBL ID | 735080 |
MeSH ID | M0186550 |
Synonyms (20)
Synonym |
---|
13274-43-6 |
4-mtad |
3h-1,2,4-triazole-3,5(4h)-dione, 4-methyl- |
4-methyl-3h-1,2,4-triazole-3,5(4h)-dione |
n-methyl-1,2,4-triazolinedione |
4-methyl-1,2,4-triazole-3,5-dione |
4-methyl-[1,2,4]triazole-3,5-dione |
4-methyl-1,2,4-triazoline-3,5-dione |
FT-0636860 |
AKOS015916255 |
SCHEMBL735080 |
MB00223 |
DTXSID30157738 |
4-methyl-4,5-dihydro-3h-1,2,4-triazole-3,5-dione |
J-006216 |
4-methyl urazole |
A888262 |
SY315499 |
mfcd00013440 |
EN300-345085 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 19.99
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (19.99) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (16.67%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (83.33%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |